Degenerative Disc Disease Clinical Trial
— SELECTOfficial title:
A Prospective, Randomized, Intra-Patient Controlled, Multi-Center Clinical Investigation Evaluating OSTEOAMP SELECT Fibers Versus Infuse Bone Graft as Autograft Substitute in Lumbar Fusion Procedures
NCT number | NCT05405374 |
Other study ID # | BGS-21-01 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | May 6, 2022 |
Est. completion date | October 2025 |
The objective of this clinical study is to compare OSTEOAMP SELECT Fibers to Infuse Bone Graft, in terms of effectiveness and safety, when used as a bone graft substitute in in skeletally mature patients qualified for 2-lumbar interbody fusion (LIF) by means of an intra-patient control model.
Status | Recruiting |
Enrollment | 101 |
Est. completion date | October 2025 |
Est. primary completion date | October 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years to 80 Years |
Eligibility | Inclusion Criteria: - Skeletally mature male or female patient, at least 21 years of age and no more than 80 years of age, inclusive, at the time of surgery; - Has symptomatic degenerative disc disease (DDD) of the lumbosacral spine in two levels (L2 to S1). Lumbar DDD is defined as discogenic back pain with or without radicular symptoms confirmed by patient history and radiographic studies - Has radiographic evidence (e.g. CT, MRI, x-ray, etc.) of degenerative lumbosacral disease including instability up to and including Grade 1 spondylolisthesis at the involved level(s) - Requires fusion (i.e., symptomatic) at 2 adjacent or non-adjacent levels from L2 to S1; - Non-responsive to non-operative treatment (e.g., bed rest, physical therapy, medication,spinal injection, manipulation, and/or TENS) for at least 6 months; - Willing and able to comply with the study protocol (including post-operative clinical and radiographic evaluations and required rehabilitation plan) and able to understand and sign the Informed Consent. Exclusion Criteria: - Previous lumbar spine surgery with the exception of discectomy and/or laminectomy at the target levels. - Lumbar scoliosis >30 degrees. - Documented history of osteoporosis, osteomalacia, Paget's disease or metabolic bone disease - Morbidly obese, as defined by a Body Mass Index (BMI) >40 kg/m2. - Documented history of uncontrolled diabetes mellitus - Presence of active malignancy or prior history of malignancy (non-invasive basal cell carcinoma of the skin is allowed). - Overt or active bacterial infection, either local to surgical space or systemic. - Chronic use of steroids (defined as more than 6 weeks of steroid use within 12 months of surgery, other than episodic use or inhaled corticosteroids) - Co-morbidities, which in the investigator's opinion, precludes the subject from being a surgical candidate. - Autoimmune disease, which in the investigator's opinion, is known to affect bone metabolism or the spine (e.g., spondyloarthropathies, juvenile arthritis, rheumatoid arthritis, Graves' disease, Hashimoto's thyroiditis). - Any endocrine or metabolic disorder, which in the investigator's opinion, is known to affect osteogenesis (e.g., Paget's disease, renal osteodystrophy, Ehlers- Danlos syndrome, or osteogenesis imperfecta). - History of hypersensitivity and/or allergy to any of the agents used to process OSTEOAMP SELECT, including bacitracin, polymyxin B sulfate, and gentamicin. - Known hypersensitivity or allergy to any components of the study treatments including, but not limited to bone morphogenetic proteins (BMPs); injectable collagen; protein pharmaceuticals (e.g., monoclonal antibodies or gamma globulins); bovine collagen products; and/or instrumentation materials (e.g., titanium, titanium alloy, cobalt chrome,cobalt chrome alloy, or PEEK). - Is a prisoner. - Treatment with an investigational therapy (drug, device, and/or biologic) targeting spinal conditions within 3 months prior to implantation surgery, treatment with any other investigational therapies within 30 days prior to implantation surgery, or such treatment is planned during the 24-month period following implantation of the study treatment. - Pregnant or nursing. Females of child-bearing potential must agree not to become pregnant for the duration of the study. - A history of alcohol and/or drug abuse within 6 months prior to screening or exhibits evidence, in the investigator's opinion, of alcohol/drug abuse at screening. - Current history of heavy nicotine use (e.g. more than 20 cigarettes per day). - Any condition, which in the investigator's opinion, would interfere with the subject's ability to comply with study instructions, which might confound data interpretation. |
Country | Name | City | State |
---|---|---|---|
United States | Austin Neurosurgeons | Austin | Texas |
United States | New England Baptist Hospital | Boston | Massachusetts |
United States | West Virginia University | Morgantown | West Virginia |
United States | Tennessee Orthopaedic Alliance | Nashville | Tennessee |
United States | Yale University | New Haven | Connecticut |
United States | Orthopaedic Institute of Western Kentucky | Paducah | Kentucky |
United States | OrthoVirginia | Richmond | Virginia |
United States | Spine Institute of Louisiana | Shreveport | Louisiana |
United States | Kansas Joint and Spine Specialists | Wichita | Kansas |
Lead Sponsor | Collaborator |
---|---|
Bioventus LLC |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Functional Impairment | Derived from the Oswestry Low Back Pain Questionnaire to quantify low back pain and function. Zero is equated with no disability and 100 is the maximum disability possible. | 24 Months | |
Other | Back Pain | Visual Analogue Scale (VAS) change in back pain from baseline to 24 month follow up assessed at time frames: Pre-Op, 6 weeks, 3 month, 6 month, 12 month, 24 month.
Visual Analogue Scale is rated from 0 - 10 cm (no pain - worst possible pain) |
24 Months | |
Other | Leg Pain | Visual Analogue Scale (VAS) change in leg pain from baseline to 24 month follow up assessed at time frames: Pre-Op, 6 weeks, 3 month, 6 month, 12 month, 24 month.
Visual Analogue Scale is rated from 0 - 10 cm (no pain - worst possible pain) |
24 Months | |
Primary | Fusion Status | Radiographic fusion as defined by the Image Review Charter and assessed by an independent core laboratory. | 12 Months | |
Secondary | Fusion Status | Radiographic fusion as defined by the Image Review Charter and assessed by an independent core laboratory. | 24 Months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04848376 -
Post-Market Clinical Follow-up Study of A-SPINE's Products
|
||
Active, not recruiting |
NCT05114135 -
TLIF Osteo3 ZP Putty Study (Also Known as the TOP Fusion Study)
|
N/A | |
Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
Withdrawn |
NCT03223701 -
Efficacy of Using Solum IV and BMC With GFC in TLIF
|
Phase 4 | |
Completed |
NCT04057235 -
Retrospective Review of Integrity Implants FlareHawk® for Lumbar Fusion
|
||
Not yet recruiting |
NCT06000319 -
Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion
|
||
Active, not recruiting |
NCT02969616 -
Trinity Elite in Lumbar Fusion
|
||
Completed |
NCT02558621 -
New Robotic Assistance System for Spinal Fusion Surgery
|
N/A | |
Completed |
NCT02104167 -
Retrospective/Prospective Data Collection on the LDR ROIC Interbody Fusion Device With VerteBRIDGE Plating
|
||
Terminated |
NCT00974623 -
Bone Graft Materials Observational Registry
|
N/A | |
Completed |
NCT00965380 -
Trinity Evolution in Posterior or Transforaminal Lumbar Interbody Fusion (PLIF/TLIF)
|
||
Completed |
NCT00996073 -
Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion
|
Phase 2 | |
Completed |
NCT00758719 -
Evaluate Effectiveness of the Biomet Lumbar Spinal Fusion System
|
||
Completed |
NCT00165893 -
Comparison of IDD Therapy and Non-surgical Treatment for Low Back Pain Caused by Degenerative Disc Disease
|
Phase 4 | |
Terminated |
NCT01494493 -
Pivotal Study of rhBMP-2/ACS/Allograft Bone Dowel for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease
|
N/A | |
Recruiting |
NCT04727385 -
Intervertebral DXM Gel Injection in Adults With Painful Lumbar Degenerative Disc Disease
|
N/A | |
Completed |
NCT04849429 -
Intra-discal Injection of Platelet-rich Plasma (PRP) Enriched With Exosomes in Chronic Low Back Pain
|
Phase 1 | |
Recruiting |
NCT04469387 -
Preventive Effect of Limited Decompression on Adjacent Segment Following Posterior Lumbar Interbody Fusion
|
N/A | |
Recruiting |
NCT04056520 -
Clinical and Radiological Outcomes of Posterior Cervical Fusion With Medtronic Infinity Occipitocervical-Upper Thoracic (OCT) System
|
||
Completed |
NCT04119466 -
Stabilizing Training in Degenerative Disc Disease
|
N/A |